Search

Search Constraints

You searched for: Author/Creator Panzara, Michael A.

Search Results

1. Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy. (12th September 2017)

2. Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings. (12th September 2017)

3. Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients. (8th November 2016)

5. Genotyping single nucleotide polymorphisms for allele-selective therapy in Huntington disease. (June 2020)

6. New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures. Issue 1 (6th January 2020)

7. Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS. (4th October 2016)

8. Teriflunomide slows BVL in relapsing MS: A reanalysis of the TEMSO MRI data set using SIENA. Issue 5 (September 2017)